Callan JMB and Alabama State University Announce Strategic Partnership to Advance U.S. Pharmaceutical Manufacturing and Supply Chain Resilience
Callan JMB announced a strategic partnership with Alabama State University to develop an integrated pharmaceutical manufacturing ecosystem designed to strengthen domestic production and supply chain resilience. Under the agreement, Callan JMB would receive 21% of gross revenue from qualifying manufacturing operations, which management estimates could represent a potential $414 million five-year revenue opportunity for the company.
Key figures
- Revenue share percentage
- 21%
- Five year revenue opportunity
- $414 million
- Potential annual cjmb revenue
- $105 million
- Potential annual gross revenue
- $500 million
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.